Condition: CPPD - Calcium Pyrophosphate Deposition Disease · Gout · Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
This study at IRCCS Galeazzi - Sant'Ambrogio Hospital involves patients with gout, CPPD, and osteoarthritis as a control group. Patients will receive routine care with regular clinical, laboratory, and imaging assessments every six months, alongside urgent visits as needed. The study aims to understand crystal deposits in joints and blood vessels and monitor their progression over time, assessing how these deposits respond to standard treatments and if they are associated with cardiovascular complications. Data will be collected from medical records over a follow-up period of up to 10 years, offering long-term insights into disease impact and treatment effectiveness.
This description comes directly from the study's public registry record.
Georgios Filippou, MD · 0039 0283502707 · georgios.filippou@grupposandonato.it
Silvia Sirotti, MD · 0039 0283502708 · silvia.sirotti@grupposandonato.it
Always discuss trial participation with your own doctor first.
| IRCCS Ospedale Galeazzi-Sant'Ambrogio | Milan, Milano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07504146